ELCC 2018 | Lung cancer molecular testing: what’s next?

Keith Kerr

In this interview, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, makes predictions on what important changes are likely to take place in the field of lung cancer testing within the next year, particularly focusing on changes in molecular testing regulation and the development of new molecular tests. This video was recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland.

Share this video